The most notable medications affected by regulatory updates are tirzepatide (Mounjaro) and semaglutide (Ozempic, Wegovy)
While you can't stop the physiological effects of the GLP-1 medication on your body, you can influence the other aspects of gut health, which is multifaceted
Authors contributions AR, FK, EZ, HS, and SM contributed to the conception and design, as well as the acquisition, analysis, and interpretation of data
In patients with type 2 diabetes and chronic kidney disease (CKD), semaglutide drastically reduces the risk of major kidney disease events, MACE, and all-cause death while also slowing down loss of kidney function, according to full results of the FLOW trial
That's exactly what we help you prepare for
Internal hemorrhoids themselves do not directly cause constipation, but they can contribute to it